| John Charles Pearce, MD | |
|
1015 East 32nd, 101, Austin, TX 78705 | |
| (512) 477-6341 | |
| (512) 477-1148 |
| Full Name | John Charles Pearce |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 42 Years |
| Location | 1015 East 32nd, Austin, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710979547 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | G6590 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Encompass Home Health Of Central Texas | San antonio, TX | Home health agency |
| Ascension Seton Medical Center Austin | Austin, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Seton Family Of Doctors | 0941333280 | 663 |
News Archive
The Kansas City Star reports that Missouri led the country in 2008 in efficiency in using federal dollars to combat Medicaid fraud. "The state recovered almost $29.8 million in 2008, the most recent year for which comparative data are available, while receiving about $1.6 million in federal Medicaid fraud grants. That equates to $18.81 recovered for every dollar received — 43 cents better than the next-best state" (Noble, 1/12).
Vanda Pharmaceuticals Inc. announced today that the U.S. Patent and Trademark Office has issued a notice of allowance for its patent application of a microsphere, long-acting injectable formulation of its antipsychotic product, Fanapt™ (iloperidone). When issued, this U.S. patent will expire on October 30, 2022, and in addition, the U.S. Patent and Trademark Office has granted a patent term adjustment of 300 days, leading to an effective expiration date of August 26, 2023.
Is screening or treatment for prostate cancer the reason for decreased mortality in the USA, compared to the UK?
Over the next ten years, 30 million more seniors will pour into Medicare, which already eats up 12 percent of the federal budget and 20 percent of all health spending, NPR reports. That has deficit hawks worried. Douglas Holtz-Eakin, a former Congressional Budget Office director, says, "If you look past the next eight to 10 years, Medicare is the deficit problem… And there's simply no way we can address our fiscal problems without coming to terms with Medicare's future."
Small, non-coding molecules called microRNAs are known to play an important role in cancer development. Researchers now have shown their significance is greater than previously thought, a finding that could lead to new therapeutic approaches for the most common and deadly form of ovarian cancer.
› Verified 6 days ago
| Entity Name | Orthopaedic Associates Of Central Tx Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518061092 PECOS PAC ID: 3971583840 Enrollment ID: O20040721001334 |
News Archive
The Kansas City Star reports that Missouri led the country in 2008 in efficiency in using federal dollars to combat Medicaid fraud. "The state recovered almost $29.8 million in 2008, the most recent year for which comparative data are available, while receiving about $1.6 million in federal Medicaid fraud grants. That equates to $18.81 recovered for every dollar received — 43 cents better than the next-best state" (Noble, 1/12).
Vanda Pharmaceuticals Inc. announced today that the U.S. Patent and Trademark Office has issued a notice of allowance for its patent application of a microsphere, long-acting injectable formulation of its antipsychotic product, Fanapt™ (iloperidone). When issued, this U.S. patent will expire on October 30, 2022, and in addition, the U.S. Patent and Trademark Office has granted a patent term adjustment of 300 days, leading to an effective expiration date of August 26, 2023.
Is screening or treatment for prostate cancer the reason for decreased mortality in the USA, compared to the UK?
Over the next ten years, 30 million more seniors will pour into Medicare, which already eats up 12 percent of the federal budget and 20 percent of all health spending, NPR reports. That has deficit hawks worried. Douglas Holtz-Eakin, a former Congressional Budget Office director, says, "If you look past the next eight to 10 years, Medicare is the deficit problem… And there's simply no way we can address our fiscal problems without coming to terms with Medicare's future."
Small, non-coding molecules called microRNAs are known to play an important role in cancer development. Researchers now have shown their significance is greater than previously thought, a finding that could lead to new therapeutic approaches for the most common and deadly form of ovarian cancer.
› Verified 6 days ago
| Entity Name | Seton Family Of Doctors |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588997233 PECOS PAC ID: 0941333280 Enrollment ID: O20100806000260 |
News Archive
The Kansas City Star reports that Missouri led the country in 2008 in efficiency in using federal dollars to combat Medicaid fraud. "The state recovered almost $29.8 million in 2008, the most recent year for which comparative data are available, while receiving about $1.6 million in federal Medicaid fraud grants. That equates to $18.81 recovered for every dollar received — 43 cents better than the next-best state" (Noble, 1/12).
Vanda Pharmaceuticals Inc. announced today that the U.S. Patent and Trademark Office has issued a notice of allowance for its patent application of a microsphere, long-acting injectable formulation of its antipsychotic product, Fanapt™ (iloperidone). When issued, this U.S. patent will expire on October 30, 2022, and in addition, the U.S. Patent and Trademark Office has granted a patent term adjustment of 300 days, leading to an effective expiration date of August 26, 2023.
Is screening or treatment for prostate cancer the reason for decreased mortality in the USA, compared to the UK?
Over the next ten years, 30 million more seniors will pour into Medicare, which already eats up 12 percent of the federal budget and 20 percent of all health spending, NPR reports. That has deficit hawks worried. Douglas Holtz-Eakin, a former Congressional Budget Office director, says, "If you look past the next eight to 10 years, Medicare is the deficit problem… And there's simply no way we can address our fiscal problems without coming to terms with Medicare's future."
Small, non-coding molecules called microRNAs are known to play an important role in cancer development. Researchers now have shown their significance is greater than previously thought, a finding that could lead to new therapeutic approaches for the most common and deadly form of ovarian cancer.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John Charles Pearce, MD 1015 E 32nd St, Ste 101, Austin, TX 78705-2700 Ph: (512) 477-6341 | John Charles Pearce, MD 1015 East 32nd, 101, Austin, TX 78705 Ph: (512) 477-6341 |
News Archive
The Kansas City Star reports that Missouri led the country in 2008 in efficiency in using federal dollars to combat Medicaid fraud. "The state recovered almost $29.8 million in 2008, the most recent year for which comparative data are available, while receiving about $1.6 million in federal Medicaid fraud grants. That equates to $18.81 recovered for every dollar received — 43 cents better than the next-best state" (Noble, 1/12).
Vanda Pharmaceuticals Inc. announced today that the U.S. Patent and Trademark Office has issued a notice of allowance for its patent application of a microsphere, long-acting injectable formulation of its antipsychotic product, Fanapt™ (iloperidone). When issued, this U.S. patent will expire on October 30, 2022, and in addition, the U.S. Patent and Trademark Office has granted a patent term adjustment of 300 days, leading to an effective expiration date of August 26, 2023.
Is screening or treatment for prostate cancer the reason for decreased mortality in the USA, compared to the UK?
Over the next ten years, 30 million more seniors will pour into Medicare, which already eats up 12 percent of the federal budget and 20 percent of all health spending, NPR reports. That has deficit hawks worried. Douglas Holtz-Eakin, a former Congressional Budget Office director, says, "If you look past the next eight to 10 years, Medicare is the deficit problem… And there's simply no way we can address our fiscal problems without coming to terms with Medicare's future."
Small, non-coding molecules called microRNAs are known to play an important role in cancer development. Researchers now have shown their significance is greater than previously thought, a finding that could lead to new therapeutic approaches for the most common and deadly form of ovarian cancer.
› Verified 6 days ago
Michael W Burris, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 12201 Renfert Way, Suite 370, Austin, TX 78758 Phone: 512-617-1989 Fax: 512-617-2065 | |
Dr. William Parker Abblitt, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4700 Seton Center Pkwy Ste 200, Austin, TX 78759 Phone: 512-439-1000 | |
Matthew David Ellington, M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 1301 Barbara Jordan Blvd, Suite 300, Austin, TX 78723 Phone: 512-478-8116 Fax: 512-478-9368 | |
Ryan Michael Tibbetts, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4700 Seton Center Pkwy, Ste 200, Austin, TX 78759 Phone: 512-439-1000 Fax: 512-439-1081 | |
Dr. Kevin J. Bozic, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1301 W 38th St, Ste 102, Austin, TX 78705 Phone: 512-454-4561 Fax: 512-406-7330 | |
Dr. Eugene P Schoch Iii, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 1015 East 32nd St, Suite 101, Austin, TX 78705 Phone: 512-477-6341 Fax: 512-477-1148 | |
Dr. Kathleen Dolores Rickert-madden, M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 1301 Barbara Jordan Blvd Ste 300, Austin, TX 78723 Phone: 512-478-8116 Fax: 512-478-9368 |